Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,160,324 |
|
|||||
| News | - | ||||||
| Day High | 2.52 | Low High |
|||||
| Day Low | 2.36 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | ADPT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 2.08% | 2.45 | 18:35:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.41 | 2.36 | 2.52 | 2.51 | 2.40 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,561 | 2,160,324 | US$ 2.42 | US$ 5,234,138 | - | 2.28 - 9.0799 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:55:56 | 75 | US$ 2.50 | USD |
Adaptive Biotechnologies Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 364.18M | 145.09M | - | 170.28M | -225.25M | -1.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Adaptive Biotechnologies News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADPT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.01 | 3.11 | 2.28 | 2.56 | 2,636,308 | -0.56 | -18.60% |
| 1 Month | 3.24 | 3.335 | 2.28 | 2.79 | 2,230,101 | -0.79 | -24.38% |
| 3 Months | 3.95 | 4.345 | 2.28 | 3.32 | 1,683,747 | -1.50 | -37.97% |
| 6 Months | 4.09 | 5.49 | 2.28 | 3.90 | 1,617,495 | -1.64 | -40.10% |
| 1 Year | 8.61 | 9.0799 | 2.28 | 4.98 | 1,392,700 | -6.16 | -71.54% |
| 3 Years | 42.45 | 44.97 | 2.28 | 11.43 | 1,160,251 | -40.00 | -94.23% |
| 5 Years | 39.01 | 71.25 | 2.28 | 20.79 | 1,072,972 | -36.56 | -93.72% |
Adaptive Biotechnologies Description
| Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. |
